JP Stock MarketDetailed Quotes

7775 Daiken Medical

Watchlist
  • 507
  • +1+0.20%
20min DelayNot Open Dec 25 15:30 JST
16.14BMarket Cap14.73P/E (Static)

Daiken Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Total revenue
6.71%9.75B
4.60%2.34B
5.74%2.58B
9.05%2.46B
7.53%2.36B
6.99%9.14B
5.70%2.24B
4.59%2.44B
7.08%2.26B
11.09%2.2B
Cost of revenue
2.88%5.77B
-7.21%1.44B
3.80%1.5B
7.25%1.43B
9.50%1.4B
15.45%5.61B
21.44%1.55B
10.07%1.44B
14.79%1.33B
15.60%1.28B
Gross profit
12.80%3.98B
31.17%904.43M
8.54%1.08B
11.64%1.04B
4.78%958.01M
-4.17%3.53B
-18.17%689.5M
-2.42%998.96M
-2.33%927.37M
5.33%914.33M
Operating expense
2.57%2.54B
15.61%699.22M
-6.64%592.14M
3.08%629.15M
-1.19%618.84M
-2.27%2.48B
-3.29%604.8M
-3.23%634.22M
-3.61%610.36M
1.17%626.32M
Operating profit
36.81%1.44B
142.25%205.21M
34.93%492.12M
28.12%406.15M
17.76%339.17M
-8.38%1.05B
-61.00%84.71M
-0.98%364.73M
0.22%317.01M
15.66%288.01M
Net non-operating interest income (expenses)
-21.69%-4.83M
-15.60%-1.21M
-27.50%-1.21M
-21.05%-1.2M
-23.21%-1.21M
-6.10%-3.97M
-20.67%-1.05M
-4.40%-949K
0.90%-993K
-1.88%-978K
Non-operating interest income
--0
--0
--0
----
----
--0
--0
--0
----
----
Non-operating interest expense
21.69%4.83M
15.60%1.21M
27.50%1.21M
21.05%1.2M
23.21%1.21M
6.10%3.97M
20.67%1.05M
4.40%949K
-0.90%993K
1.88%978K
Net investment income
526.72%2.91M
3,000.00%868K
29.45%-194K
-6.06%93K
249.84%2.14M
-60.14%464K
-97.15%28K
-759.38%-275K
201.02%99K
96.78%612K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
60.90%-11.19M
71.16%-8.26M
-6,936.49%-5.06M
4,414.00%2.16M
-26K
-2,658.82%-28.61M
-20,953.68%-28.63M
135.24%74K
87.28%-50K
0
Less:Other special charges
-60.90%11.19M
-71.16%8.26M
6,936.49%5.06M
---2.16M
--26K
2,658.82%28.61M
20,953.68%28.63M
-135.24%-74K
----
----
Other non-operating income (expenses)
158.71%6.92M
79.89%2M
589.49%2.03M
37.74%1.08M
275.73%1.8M
-34.27%2.67M
-20.14%1.11M
-67.29%295K
29.65%787K
-58.93%478K
Income before tax
40.14%1.44B
253.60%198.62M
34.03%487.69M
28.86%408.28M
18.66%341.88M
-10.97%1.03B
-74.30%56.17M
-1.14%363.88M
0.45%316.85M
15.60%288.13M
Income tax
43.10%447.86M
204.56%98.17M
30.63%137.21M
28.34%115.37M
13.18%97.11M
-2.28%312.96M
-35.09%32.23M
-1.11%105.04M
-1.72%89.89M
17.63%85.8M
Net income
38.84%988.6M
319.65%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Net income continuous operations
38.84%988.6M
319.63%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Noncontrolling interests
Net income attributable to the company
38.84%988.6M
319.65%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
38.84%988.6M
319.65%100.45M
35.40%350.48M
29.06%292.91M
20.98%244.77M
-14.32%712.06M
-85.83%23.94M
-1.16%258.84M
1.34%226.96M
14.76%202.33M
Gross dividend payment
Basic earnings per share
38.81%34.41
315.48%3.49
35.41%12.2
29.11%10.2
21.02%8.52
-14.31%24.79
-85.71%0.84
-1.21%9.01
1.41%7.9
14.66%7.04
Diluted earnings per share
38.81%34.41
318.88%3.49
35.40%12.1997
29.06%10.1958
21.02%8.52
-14.31%24.79
-85.83%0.8332
-1.16%9.01
1.41%7.9
14.66%7.04
Dividend per share
5.00%21
9.09%12
0
0.00%9
0
0.00%20
0.00%11
0
0.00%9
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Total revenue 6.71%9.75B4.60%2.34B5.74%2.58B9.05%2.46B7.53%2.36B6.99%9.14B5.70%2.24B4.59%2.44B7.08%2.26B11.09%2.2B
Cost of revenue 2.88%5.77B-7.21%1.44B3.80%1.5B7.25%1.43B9.50%1.4B15.45%5.61B21.44%1.55B10.07%1.44B14.79%1.33B15.60%1.28B
Gross profit 12.80%3.98B31.17%904.43M8.54%1.08B11.64%1.04B4.78%958.01M-4.17%3.53B-18.17%689.5M-2.42%998.96M-2.33%927.37M5.33%914.33M
Operating expense 2.57%2.54B15.61%699.22M-6.64%592.14M3.08%629.15M-1.19%618.84M-2.27%2.48B-3.29%604.8M-3.23%634.22M-3.61%610.36M1.17%626.32M
Operating profit 36.81%1.44B142.25%205.21M34.93%492.12M28.12%406.15M17.76%339.17M-8.38%1.05B-61.00%84.71M-0.98%364.73M0.22%317.01M15.66%288.01M
Net non-operating interest income (expenses) -21.69%-4.83M-15.60%-1.21M-27.50%-1.21M-21.05%-1.2M-23.21%-1.21M-6.10%-3.97M-20.67%-1.05M-4.40%-949K0.90%-993K-1.88%-978K
Non-operating interest income --0--0--0----------0--0--0--------
Non-operating interest expense 21.69%4.83M15.60%1.21M27.50%1.21M21.05%1.2M23.21%1.21M6.10%3.97M20.67%1.05M4.40%949K-0.90%993K1.88%978K
Net investment income 526.72%2.91M3,000.00%868K29.45%-194K-6.06%93K249.84%2.14M-60.14%464K-97.15%28K-759.38%-275K201.02%99K96.78%612K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges) 60.90%-11.19M71.16%-8.26M-6,936.49%-5.06M4,414.00%2.16M-26K-2,658.82%-28.61M-20,953.68%-28.63M135.24%74K87.28%-50K0
Less:Other special charges -60.90%11.19M-71.16%8.26M6,936.49%5.06M---2.16M--26K2,658.82%28.61M20,953.68%28.63M-135.24%-74K--------
Other non-operating income (expenses) 158.71%6.92M79.89%2M589.49%2.03M37.74%1.08M275.73%1.8M-34.27%2.67M-20.14%1.11M-67.29%295K29.65%787K-58.93%478K
Income before tax 40.14%1.44B253.60%198.62M34.03%487.69M28.86%408.28M18.66%341.88M-10.97%1.03B-74.30%56.17M-1.14%363.88M0.45%316.85M15.60%288.13M
Income tax 43.10%447.86M204.56%98.17M30.63%137.21M28.34%115.37M13.18%97.11M-2.28%312.96M-35.09%32.23M-1.11%105.04M-1.72%89.89M17.63%85.8M
Net income 38.84%988.6M319.65%100.45M35.40%350.48M29.06%292.91M20.98%244.77M-14.32%712.06M-85.83%23.94M-1.16%258.84M1.34%226.96M14.76%202.33M
Net income continuous operations 38.84%988.6M319.63%100.45M35.40%350.48M29.06%292.91M20.98%244.77M-14.32%712.06M-85.83%23.94M-1.16%258.84M1.34%226.96M14.76%202.33M
Noncontrolling interests
Net income attributable to the company 38.84%988.6M319.65%100.45M35.40%350.48M29.06%292.91M20.98%244.77M-14.32%712.06M-85.83%23.94M-1.16%258.84M1.34%226.96M14.76%202.33M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 38.84%988.6M319.65%100.45M35.40%350.48M29.06%292.91M20.98%244.77M-14.32%712.06M-85.83%23.94M-1.16%258.84M1.34%226.96M14.76%202.33M
Gross dividend payment
Basic earnings per share 38.81%34.41315.48%3.4935.41%12.229.11%10.221.02%8.52-14.31%24.79-85.71%0.84-1.21%9.011.41%7.914.66%7.04
Diluted earnings per share 38.81%34.41318.88%3.4935.40%12.199729.06%10.195821.02%8.52-14.31%24.79-85.83%0.8332-1.16%9.011.41%7.914.66%7.04
Dividend per share 5.00%219.09%1200.00%900.00%200.00%1100.00%90
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
TRaaS On Product
6696
410 +24.24%
CyberStep
3810
283 +23.04%
GMO AD Partners
4784
961 +18.50%
Bplats
4381
521 +18.14%
General Oyster
3224
683 +17.15%

See the daily top gainer.